Medication for Opioid Use Disorder (MOUD)
With support from Maine DHHS, the Maine Medical Association Center for Quality Improvement (MMA-CQI) has worked with clinical experts to create the “Rapid Induction Starting in the ED” (RISE) project to provide education and assistance on best practices for initiating buprenorphine in hospital Emergency Departments (EDs) for individuals with opioid use disorder (OUD) who are interested in engaging in treatment.
Join us for Clinical Hours! Meetings take place at 12:00 noon on the first Tuesday of every month – next meeting is July 5th at noon*
MOUD IMPLEMENTATION TOOLKIT – DOWNLOAD A COPY
- Implementation Guidance and Measures
- Regulatory FAQ’s
- Buprenorphine formulations, side effects, and tips
- Recommended protocols
- Recommendations for starting Buprenorphine at-home
COMPANION GUIDE – DOWNLOAD A COPY
- Training materials and treatment workflows
- Billing Codes
- Literature
- Resources
QUICK RESOURCES
- SAMHSA’S FAQs About the New Buprenorphine Practice Guidelines
- Yale Model: https://medicine.yale.edu/edbup/
- ODMAP: http://www.odmap.org/
- Maine 211: https://211maine.org/
- Eyes Open: https://www.eyesopenforme.org/
- Maine Prevention Store: https://www.mainepreventionstore.com/
- ED Bridge – Emergency Buprenorphine Treatment Resources: https://cabridge.org/tools/resources/
- Clinical Opioid Withdrawal Scale
- Special Circumstances for Providing Buprenorphine –Special Circumstances for Providing Buprenorphine | SAMHSA
- Maine Opioid Response Clinical Advisory Committee: Proposed Position on the Use of Buprenorphine-Naloxone in Pregnancy
*email cstratton@mainemed.com for the meeting links.